The LCN2 gene, also known as lipocalin 2 or neutrophil gelatinase-associated lipocalin (NGAL), has emerged as a significant biomarker for a range of conditions, including acute kidney injury (49), Alzheimer’s disease (50), MS (51) and depression (52). Here, LCN2 is linked to depressive symptom measurement.